Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT6A | Q92794 | 3/20 | 0.63 |
| ▸ | CTSS | P25774 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | F2 | P00734 | 3/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.57 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.57 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.57 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.57 |
| ▸ | F10 | P00742 | 1/20 | 0.57 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27487670 | 0.98 | KAT6A (0.61) | KAT6ACTSSALDH1A1F2PRSS1 | |
| SCHEMBL6438335 | 0.86 | ALDH1A1 (0.69) | KAT6ACTSSALDH1A1CYP19A1L3MBTL1 | |
| SCHEMBL7371174 | 0.85 | ALDH1A1 (0.68) | KAT6ACTSSALDH1A1F2PRSS1 | |
| SCHEMBL7598374 | 0.85 | NPC1 (0.47) | KAT6ACTSSALDH1A1F2F10 | |
| SCHEMBL8318684 | 0.84 | CTSS (0.65) | KAT6ACTSSALDH1A1CYP19A1TPSAB1 | |
| SCHEMBL8954769 | 0.84 | KAT6A (0.63) | KAT6ACTSSALDH1A1F2CYP19A1 | |
| SCHEMBL14045828 | 0.84 | ALDH1A1 (0.59) | KAT6ACTSSALDH1A1F2PRSS1 | |
| SCHEMBL8428166 | 0.83 | RAPGEF3 (0.58) | KAT6ACTSSALDH1A1L3MBTL1POLB | |
| SCHEMBL1771503 | 0.83 | CTSS (0.67) | KAT6ACTSSALDH1A1F2CYP19A1 | |
| SCHEMBL3147274 | 0.82 | ALDH1A1 (0.73) | ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6774212-B2 | FOR THERAPY OF VIRAL INFECTION OR AS AN ASSAY STANDARD OR REAGENT | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-08-10 | — | — | US | disclosed |